Attovia Therapeutics has successfully completed an initial public offering that raised two hundred and eighty-nine million dollars to finance its pipeline of treatments for skin disorders and inflammatory conditions. This
Biotech
27Articles
Expedition Therapeutics has announced a successful fundraising round to advance its experimental treatment for chronic obstructive pulmonary disease. The biotechnology firm raised $115 million in a Series B investment, bringing
Thalia Therapeutics plc, the AIM-quoted RNA therapeutics developer, has described its proposed acquisition of Sanmirna Therapeutics alongside a £2.75 million oversubscribed fundraising as a transformational step forward. Shareholders are scheduled
Oxford Nanopore expects first-half revenue of about £116.5 million after weaker trading in China and the Middle East and slower order timing in the Americas.
When a Swiss pharmaceutical giant agrees to pay up to $1.5 billion for a British biotech that is not yet selling a single medicine, the first instinct in London is
In a significant and ambitious move, GlaxoSmithKline (GSK) has entered into a definitive agreement to acquire the American biotechnology company Nuvalent for a staggering $10.6 billion. This acquisition, reported to
In a significant development within the pharmaceutical sector, GlaxoSmithKline (GSK) has announced a £45 million collaboration with Engitix, a biotech firm emerging from the academic institution of University College London
The University of Cambridge is reaping substantial rewards from its innovative approach, granting six seasoned entrepreneurs a golden access card to explore its departments for breakthrough technologies ready for rapid
The founders of BioNTech, the German biotechnology company noted for its successful Covid-19 vaccine, are set to depart by the end of the year. Ugur Sahin, the chief executive, and
A small biotech company, Roquefort Therapeutics, is set to enhance its portfolio through the acquisition of rights to a clinical-stage cancer treatment in a reverse takeover valued at £32 million.
The controlling shareholder of Novo Nordisk has joined a coalition of European venture capital firms to mobilise increased funding amidst concerns that Europe’s life sciences sector may fall behind its
More than 200 chief executives from the world of British biotechnology have united in a passionate appeal to the Chancellor, warning that proposed increases in taxes or business rates for
An unexpected breakthrough by three British biologists could revolutionise the way breast milk is stored, presenting both health and commercial prospects for families and investors alike. BoobyBiome, a biotechnology start-up
World leaders gathered in Beijing were momentarily caught off guard when Xi Jinping, Vladimir Putin and Kim Jongun were overheard discussing the future of human longevity and the potential for
A leading biopharmaceutical business saw its shares tumble by almost 40 per cent after results from a trial of its much-anticipated weight loss pill failed to meet market expectations. Viking
Shares in Oxford Nanopore surged as the FTSE 250 gene-sequencing specialist reported stronger than expected sales for the first half of 2025. The company expects to post revenues of around
- 1
- 2